Purchase Order 75N93023P01252
Award Date
9/12/23
Potential Completion Date
10/27/23
Potential Value
$23K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Dexorgen Inc.
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $25,770.00 firm-fixed price purchase order to Dexorgen Inc., dba Codex Biosolutions Inc., a minority-owned small business, to provide HTLV envelope protein production services. The purpose is to construct stable cell lines to increase yields of HTLV-1 envelope proteins for structural analysis and research conducted by the Vaccine Research Center (VRC). This sole-source...
This $18,000 firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. Codex Biosolutions provides cell-based assay products and services to support research and development activities for government agencies, pharmaceutical companies, and other institutes. Under this contract, Codex is tasked with delivering specialized cell lines,...
This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract,...
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $35,025 firm fixed price purchase order to Codex Biosolutions Inc. under a non-competitive solicitation. Codex will generate a stable P/Q type calcium channel CaV2.1 cell line by cloning specified channel proteins into HEK293 cells and introducing an additional channel to control calcium flux, as described in the attached statement of work. The one-year contract has a period of performance from...
This federal contract award to Dexorgen Inc., doing business as Codex Biosolutions Inc., was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH). The $24,000.00 firm-fixed price purchase order is for the "GENERATION AND CHARACTERIZATION IPSC DERIVED BRAIN ORGANOIDS FROM BAIN TYPE X-LINKED MENTAL RETARDATION SYNDROME (MRXSB)". Codex Biosolutions is a minority-owned small disadvantaged business that...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,950.00 firm fixed price purchase order to Bio X Cell, LLC, a for-profit limited liability company. The contract is for the delivery of BIO X CELL AB 1000MG and has an ultimate completion date of August 7, 2017. This award supports COVID-19 research as well as research on vaccines and infectious diseases at the NIAID, and Bio X Cell has...
This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $555,600.00 contract was awarded to IDT Biologika GMBH, a German biotechnology company, for the development and manufacture of toxoid fusion proteins and master cell banks. The contract has a total ceiling value of $1,693,261.00 and is a delivery order with a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,307.50 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation doing business as Bio-Techne. The contract is for the delivery of RNASCOPE HIPLEX assay reagents and probes to support research efforts in Newark, California, over a period of three months concluding on October 31,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,095.20 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division. Under the terms of the contract, Agilent will provide 17 single lot-matched fluorescent DNA probe labeling kits, 100 lot-matched cDNA expression microarrays, gene expression hybridization and wash pack kits, and shipping and handling services in...